Pc. Rakestraw et al., INVOLVEMENT OF NITRIC-OXIDE IN INHIBITORY NEUROMUSCULAR-TRANSMISSION IN EQUINE JEJUNUM, American journal of veterinary research, 57(8), 1996, pp. 1206-1213
Objectives-To evaluate the the role of nitric oxide (NO), vasoactive i
ntestinal peptide (VIP), and a transmitter acting through an apamin-se
nsitive mechanism in mediating inhibitory transmission in the equine j
ejunal circular muscle, and to determine the distribution of VIP-and N
O-producing nerve fibers in the myenteric plexus and circular muscle.
Procedure-Circular muscle strips were suspended in tissue baths contai
ning an oxygenated modified Krebs solution and attached to isometric f
orce transducers. Responses to electrical field stimulation (EFS), tet
rodotoxin, the NO antagonists L-N-nitro-arginine-methyl-ester (L-NAME)
and N-nitro-L-arginine, apamin, VIP, authentic NO, and the NO donar s
odium nitroprusside were tested. Immunostaining for VIP-like and NADPH
diaphorase histochemical staining were performed on paraformaldehyde-
fixed tissue. Results-Subpopulations of myenteric neurons and nerve fi
bers in the circular muscle were positive for NADPH diaphorase,and VIP
-like staining. EFS caused a frequency-dependent inhibition of contrac
tile activity. Te trodotoxin prevented the EFS-induced inhibition of c
ontractions. L-NAME (200 mu M) and apamin (0.3 mu M significantly (P <
0.01) reduced EFS-stimulated inhibition of contractile activity at mo
st frequencies tested. The effects of L-NAME and apamin were additive.
in their combined presence, EFS-induced excitation instead inhibition
(196.7% increase at 5 Hz, n = 28, P < 0.01). inhibition of contractil
e activity by EFS was mimicked by sodium nitroprusside. Authentic NO (
3-6 mu M) abolished contractile activity. VIP induced a dose-dependent
inhibition of contractile activity (89.1 +/- 6.3% reduction at approx
imately 0.3 mu M, n = 16). Antagonism of NO syn thesis did not alter t
he response to VIP. Conclusion-NO, VIP, and a substance acting through
an apamin-sensitive mechanism appear to comediate inhibitory transmis
sion in the equine jejunal circular muscle. Clinical Relevance-These f
indings may suggest new therapeutic targets for motility disorders, su
ch as agents that inhibit the synthesis or actions of NO.